News
Calyxt to Present at Upcoming Conferences
May 17, 2022
ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the...
Read More
Calyxt Reports First Quarter 2022 Financial Results
May 5, 2022
Achieved technical BioFactory™ and AIML milestones to support customer demand-driven molecule development at scale Progressed relationships with an expanding network...
Read More
Calyxt Announces Strategic Hires in Business Development and Manufacturing
April 26, 2022
Continued investment in key hires to strategically position Company for future growth and scale ROSEVILLE, Minn., April 26, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq:...
Read More
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
April 21, 2022
ROSEVILLE, Minn., April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on...
Read More
Calyxt Management Joins HCW @ Home for Virtual Fireside Chat
April 19, 2022
Roseville, MN – Tuesday, April 19, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently in...
Read More